Skip to main content Skip to navigation

Homepage contents


Facts and Figures

Since April 2000 we have:

  • Identified 1,500 innovations
  • Agreed 156 licences with external companies
  • Filed 750 patents
  • Created 100 spin-out companies
  • Raised £120 million of venture capital for those companies
  • Achieved 4 successful exits, bringing in over £2 million to Warwick


Sarissa Biomedical

In search of the stroke detector

Warwick neuroscientist, Professor Nicholas Dale, tells the Observer about the stroke detection device he invented and about Sarissa Biomedical, the spin out company set up by Warwick Ventures to commercialise the technology.


ICURe logo

Midlands ICURe 2019/20 now open for applications

Innovation to Commercialisation of University Research (ICURe) is designed to move ideas and innovation out of universities and into the marketplace, where they will have the greatest impact. If you are an Early Career Researcher and think your research might have commercial potential, find out how to apply here.